Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Jun 2022 · 1 min read
In brief
In brief
This retrospective study evaluates combined transcatheter arterial embolization and oral propranolol therapy for symptomatic infantile hepatic hemangioma in 12 patients. The treatment achieved 100% technical success with favorable outcomes in 9 of 12 cases, though complications included heart failure and hypothyroidism in some patients.
Written by the GCMD Library team from the article.
Abstract
Purpose
To assess the efficacy of transcatheter arterial embolization (TAE) plus propranolol treatment for infantile hepatic hemangioma (IHH).
Methods
A retrospective study of symptomatic IHH and hemodynamic changes in IHH was conducted between 2016 and 2019.
Results
There were five boys and seven girls with diffuse lesions (n = 7) and multifocal lesions (n = 5). Hepatomegaly and abdominal distension (n = 6) were the predominant clinical presentations. Seven patients (58.3%) had multiple cutaneous hemangiomas. Pulmonary arterial hypertension, heart failure (n = 4), and hypothyroidism (n = 4) were observed. A total of 17 TAE procedures were performed in 12 IHH cases, with a technical success rate of 100%. All patients received standard propranolol orally, and one patient was orally administered metacortandracin. Two patients died of heart failure and multiple organ dysfunction caused by an enlarged liver. In addition, one patient was not reexamined after discharge. Of the remaining nine children, the average follow-up time was 10.78 months (range 2–28 months), and they all responded well to TAE combined with oral propranolol.
Conclusion
TAE combined with propranolol is safe and effective for the treatment of IHH, demonstrating low complication rates.